TNXP: Mpox Declared a Public Health Emergency of International Concern by World Health Organization
In August 2024, the World Health Organization (WHO) declared mpox a public health emergency of international concern. The number of cases of mpox...
232 Views
TNXP: High Interest in Tonmya Seen in Initial Findings from Market Opportunity Analysis
On May 13, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the first quarter of 2024 and provided a business...
200 Views
TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025
On April 1, 2024, Tonix Pharmaceuticals Holding Corp. (TNXP) announced financial results for the fourth quarter and full year 2023 and provided a...
276 Views
Time to execute
With the commencement of enrolment for the pivotal Phase III HONOR study of TNX-102 SL in military-related post-traumatic stress disorder (PTSD),...
134 Views
HONOR study up and running
Tonix Pharmaceuticals has commenced enrolment for the Phase III HONOR study of TNX-102 SL in military-related post-traumatic stress disorder...
70 Views